{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:38:20Z","timestamp":1792816700135,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T00:00:00Z","timestamp":1481155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/bjc.2016.403","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T23:47:59Z","timestamp":1481240879000},"page":"211-217","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors"],"prefix":"10.1038","volume":"116","author":[{"given":"Elina","family":"Uusitalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roope A","family":"Kallionp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samu","family":"Kurki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Rantanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Pitk\u00e4niemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauliina","family":"Kronqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirkko","family":"H\u00e4rk\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riikka","family":"Huovinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Carpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"P\u00f6yh\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkku","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,8]]},"reference":[{"key":"BFbjc2016403_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1056\/NEJM198608283150906","volume":"315","author":"HO Adami","year":"1986","unstructured":"Adami HO, Malker B, Holmberg L, Persson I, Stone B (1986) The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315: 559\u2013563.","journal-title":"N Engl J Med"},{"key":"BFbjc2016403_CR2","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","volume":"26","author":"CK Anders","year":"2008","unstructured":"Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26: 3324\u20133330.","journal-title":"J Clin Oncol"},{"key":"BFbjc2016403_CR3","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","volume":"26","author":"AS Coates","year":"2015","unstructured":"Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thurlimann B, Senn HJ Panel Members (2015) Tailoring therapies\u2014improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer (2015) Ann Oncol 26: 1533\u20131546.","journal-title":"Ann Oncol"},{"key":"BFbjc2016403_CR4","doi-asserted-by":"crossref","unstructured":"Da Silva AV, Rodrigues FR, Pureza M, Lopes VG, Cunha KS (2015) Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas. BMC Cancer 15: 183.","DOI":"10.1186\/s12885-015-1215-z"},{"key":"BFbjc2016403_CR5","volume-title":"Mixed Models: Theory and Applications with R","author":"E Demidenko","year":"2013","unstructured":"Demidenko E (2013) Mixed Models: Theory and Applications with R. Wiley: Hoboken."},{"key":"BFbjc2016403_CR6","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1002\/ajmg.a.35585","volume":"158A","author":"DG Evans","year":"2012","unstructured":"Evans DG (2012) Are we ready for targeted early breast cancer detection strategies in women with NF1 aged 30-49 years? Am J Med Genet A 158A: 3054\u20133055.","journal-title":"Am J Med Genet A"},{"key":"BFbjc2016403_CR7","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ejhg.2011.113","volume":"19","author":"DG Evans","year":"2011","unstructured":"Evans DG, O'Hara C, Wilding A, Ingham SL, Howard E, Dawson J, Moran A, Scott-Kitching V, Holt F, Huson SM (2011) Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet 19: 1187\u20131191.","journal-title":"Eur J Hum Genet"},{"key":"BFbjc2016403_CR8","first-page":"1893","volume":"27","author":"J Finek","year":"2007","unstructured":"Finek J, Holubec L Jr, Topolcan O, Elgrova L, Skalova A, Pecen L (2007) The importance of prognostic factors in premenopausal women with breast cancer. Anticancer Res 27: 1893\u20131896.","journal-title":"Anticancer Res"},{"key":"BFbjc2016403_CR9","first-page":"275","volume":"17","author":"JM Giltnane","year":"2014","unstructured":"Giltnane JM, Balko JM (2014) Rationale for targeting the Ras\/MAPK pathway in triple-negative breast cancer. Discov Med 17: 275\u2013283.","journal-title":"Discov Med"},{"key":"BFbjc2016403_CR10","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0959-8049(94)90125-2","volume":"30A","author":"C Hsieh","year":"1994","unstructured":"Hsieh C, Pavia M, Lambe M, Lan SJ, Colditz GA, Ekbom A, Adami HO, Trichopoulos D, Willett WC (1994) Dual effect of parity on breast cancer risk. Eur J Cancer 30A: 969\u2013973.","journal-title":"Eur J Cancer"},{"key":"BFbjc2016403_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1136\/jmg.26.11.712","volume":"26","author":"SM Huson","year":"1989","unstructured":"Huson SM, Compston DA, Harper PS (1989) A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling. J Med Genet 26: 712\u2013721.","journal-title":"J Med Genet"},{"key":"BFbjc2016403_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12282-012-0384-8","volume":"19","author":"S Kobayashi","year":"2012","unstructured":"Kobayashi S, Sugiura H, Ando Y, Shiraki N, Yanagi T, Yamashita H, Toyama T (2012) Reproductive history and breast cancer risk. Breast Cancer 19: 302\u2013308.","journal-title":"Breast Cancer"},{"key":"BFbjc2016403_CR13","volume-title":"WHO Classification of Tumours of the Breast, Fourth Edition","author":"SR Lakhani","year":"2012","unstructured":"Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO Classification of Tumours of the Breast, Fourth Edition. International Agency for Research on Cancer: Lyon."},{"key":"BFbjc2016403_CR14","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1002\/ajmg.a.35550","volume":"158A","author":"SA Madanikia","year":"2012","unstructured":"Madanikia SA, Bergner A, Ye X, Blakeley JO (2012) Increased risk of breast cancer in women with NF1. Am J Med Genet A 158A: 3056\u20133060.","journal-title":"Am J Med Genet A"},{"key":"BFbjc2016403_CR15","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/hmg\/ddl016","volume":"15","author":"O Maertens","year":"2006","unstructured":"Maertens O, Prenen H, Debiec-Rychter M, Wozniak A, Sciot R, Pauwels P, De Wever I, Vermeesch JR, de Raedt T, De Paepe A, Speleman F, van Oosterom A, Messiaen L, Legius E (2006) Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 15: 1015\u20131023.","journal-title":"Hum Mol Genet"},{"key":"BFbjc2016403_CR16","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1200\/JCO.1994.12.5.888","volume":"12","author":"AJ Nixon","year":"1994","unstructured":"Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, Abner A, Recht A, Vicini F, Harris JR (1994) Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12: 888\u2013894.","journal-title":"J Clin Oncol"},{"key":"BFbjc2016403_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406: 747\u2013752.","journal-title":"Nature"},{"key":"BFbjc2016403_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.semcdb.2016.02.007","volume":"52","author":"E Rad","year":"2016","unstructured":"Rad E, Tee AR (2016) Neurofibromatosis type 1: Fundamental insights into cell signalling and cancer. Semin Cell Dev Biol 52: 39\u201346.","journal-title":"Semin Cell Dev Biol"},{"key":"BFbjc2016403_CR19","volume-title":"Neurofibromatosis: Phenotype, Natural History, and Pathogenesis","author":"VM Riccardi","year":"1986","unstructured":"Riccardi VM, Eichner JE (1986) Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Johns Hopkins University Press: Baltimore."},{"key":"BFbjc2016403_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/oxfordjournals.aje.a117079","volume":"139","author":"B Rosner","year":"1994","unstructured":"Rosner B, Colditz GA, Willett WC (1994) Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol 139: 819\u2013835.","journal-title":"Am J Epidemiol"},{"key":"BFbjc2016403_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1126\/science.277.5324.333","volume":"277","author":"K Scheffzek","year":"1997","unstructured":"Scheffzek K, Ahmadian MR, Kabsch W, Wiesm\u00fcller L, Lautwein A, Schmitz F, Wittinghofer A (1997) The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277: 333\u2013338.","journal-title":"Science"},{"key":"BFbjc2016403_CR22","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/bjc.2015.78","volume":"112","author":"OO Seminog","year":"2015","unstructured":"Seminog OO, Goldacre MJ (2015) Age-specific risk of breast cancer in women with neurofibromatosis type 1. Br J Cancer 112: 1546\u20131548.","journal-title":"Br J Cancer"},{"key":"BFbjc2016403_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/bjc.2012.535","volume":"108","author":"OO Seminog","year":"2013","unstructured":"Seminog OO, Goldacre MJ (2013) Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study. Br J Cancer 108: 193\u2013198.","journal-title":"Br J Cancer"},{"key":"BFbjc2016403_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jmg.2007.049346","volume":"44","author":"S Sharif","year":"2007","unstructured":"Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, Evans DG (2007) Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44: 481\u2013484.","journal-title":"J Med Genet"},{"key":"BFbjc2016403_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10549-014-3125-1","volume":"147","author":"W Sheridan","year":"2014","unstructured":"Sheridan W, Scott T, Caroline S, Yvonne Z, Vanessa B, David V, Karen G, Stephen C (2014) Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time? Breast Cancer Res Treat 147: 617\u2013629.","journal-title":"Breast Cancer Res Treat"},{"key":"BFbjc2016403_CR26","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1158\/1078-0432.CCR-07-5003","volume":"14","author":"H Sihto","year":"2008","unstructured":"Sihto H, Lundin J, Lehtim\u00e4ki T, Sarlomo-Rikala M, B\u00fctzow R, Holli K, Sailas L, Kataja V, Lundin M, Turpeenniemi-Hujanen T, Isola J, Heikkil\u00e4 P, Joensuu H (2008) Molecular subtypes of breast cancers detected in mammography screening and outside of screening. Clin Cancer Res 14: 4103\u20134110.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2016403_CR27","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJM198604173141603","volume":"314","author":"SA S\u00f8rensen","year":"1986","unstructured":"S\u00f8rensen SA, Mulvihill JJ, Nielsen A (1986) Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 314: 1010\u20131015.","journal-title":"N Engl J Med"},{"key":"BFbjc2016403_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","volume":"13","author":"N Tung","year":"2016","unstructured":"Tung N, Domchek SM, Stadler Z, Nathanson KL, Couch F, Garber JE, Offit K, Robson ME (2016) Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol 13: 581\u2013588.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFbjc2016403_CR29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/jid.2014.465","volume":"135","author":"E Uusitalo","year":"2015","unstructured":"Uusitalo E, Lepp\u00e4virta J, Koffert A, Suominen S, Vahtera J, Vahlberg T, P\u00f6yh\u00f6nen M, Peltonen J, Peltonen S (2015) Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol 135: 904\u2013906.","journal-title":"J Invest Dermatol"},{"key":"BFbjc2016403_CR30","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","volume":"34","author":"E Uusitalo","year":"2016","unstructured":"Uusitalo E, Rantanen M, Kallionp\u00e4\u00e4 RA, P\u00f6yh\u00f6nen M, Lepp\u00e4virta J, Yl\u00e4-Outinen H, Riccardi VM, Pukkala E, Pitk\u00e4niemi J, Peltonen S, Peltonen J (2016) Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol 34: 1978\u20131986.","journal-title":"J Clin Oncol"},{"key":"BFbjc2016403_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.bjc.6603227","volume":"95","author":"L Walker","year":"2006","unstructured":"Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I, Baralle D (2006) A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 95: 233\u2013238.","journal-title":"Br J Cancer"},{"key":"BFbjc2016403_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1534\/genetics.112.142802","volume":"192","author":"MD Wallace","year":"2012","unstructured":"Wallace MD, Pfefferle AD, Shen L, McNairn AJ, Cerami EG, Fallon BL, Rinaldi VD, Southard TL, Perou CM, Schimenti JC (2012) Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver. Genetics 192: 385\u2013396.","journal-title":"Genetics"},{"key":"BFbjc2016403_CR33","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/S0022-5347(05)68171-2","volume":"162","author":"MM Walther","year":"1999","unstructured":"Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM (1999) von Recklinghausen's disease and pheochromocytomas. J Urol 162: 1582\u20131586.","journal-title":"J Urol"},{"key":"BFbjc2016403_CR34","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/ajmg.a.35560","volume":"158A","author":"X Wang","year":"2012","unstructured":"Wang X, Levin AM, Smolinski SE, Vigneau FD, Levin NK, Tainsky MA (2012) Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area. Am J Med Genet A 158A: 3061\u20133064.","journal-title":"Am J Med Genet A"},{"key":"BFbjc2016403_CR35","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1158\/0008-5472.CAN-14-2992","volume":"75","author":"KL Wright","year":"2015","unstructured":"Wright KL, Adams JR, Liu JC, Loch AJ, Wong RG, Jo CE, Beck LA, Santhanam DR, Weiss L, Mei X, Lane TF, Koralov SB, Done SJ, Woodgett JR, Zacksenhaus E, Hu P, Egan SE (2015) Ras signaling is a key determinant for metastatic dissemination and poor survival of luminal breast cancer patients. Cancer Res 75: 4960\u20134972.","journal-title":"Cancer Res"},{"key":"BFbjc2016403_CR36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","volume":"62","author":"GF Xu","year":"1990","unstructured":"Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599\u2013608.","journal-title":"Cell"},{"key":"BFbjc2016403_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ctrv.2016.03.004","volume":"45","author":"SX Yang","year":"2016","unstructured":"Yang SX, Polley E, Lipkowitz S (2016) New insights on PI3K\/AKT pathway alterations and clinical outcomes in breast cancer. Cancer Treat Rev 45: 87\u201396.","journal-title":"Cancer Treat Rev"},{"key":"BFbjc2016403_CR38","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N","volume":"79","author":"ME Z\u00f6ller","year":"1997","unstructured":"Z\u00f6ller ME, Rembeck B, Od\u00e9n A, Samuelsson M, Angervall L (1997) Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 79: 2125\u20132131.","journal-title":"Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2016403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2016403","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2016403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:35:47Z","timestamp":1684416947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2016403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFbjc2016403"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2016.403","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,8]]},"assertion":[{"value":"11 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}